MD pediatrix Medical group provides second quarter update Pediatrix Medical group - reaffirms fy2026 adj EBITDA outlook of $280M-$300M - Con

MD pediatrix Medical group provides second quarter update Pediatrix Medical group - reaffirms fy2026 adj EBITDA outlook of $280M-$300M - Confirms Q2 payor mix remained stable - Reports no material changes in Q2 net revenue trends